PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial, page-53

  1. 9,819 Posts.
    lightbulb Created with Sketch. 1249
    There are other drugs tested that have shown modest cartilage regrowth but no clinical improvement in pain or function. FDA guidelines indicate you need all for obvious reasons. EMA and TGA are going to be very impressed with our results here. Looking to see if PR can contain his excitement today.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
23.5¢ 23.5¢ 23.0¢ $85.35K 365.1K

Buyers (Bids)

No. Vol. Price($)
10 280011 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 44703 3
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.